These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation. Bakalova R, Zhelev Z, Goudev A, Ribarov S, Nachev C. Gen Physiol Biophys; 1999 Mar; 18(1):87-97. PubMed ID: 10378123 [Abstract] [Full Text] [Related]
3. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P. Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236 [Abstract] [Full Text] [Related]
9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease. Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A. Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029 [Abstract] [Full Text] [Related]
11. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes. Griffin ME, McInerney D, Fraser A, Johnson AH, Collins PB, Owens D, Tomkin GH. Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223 [Abstract] [Full Text] [Related]
12. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation. Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC. Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463 [Abstract] [Full Text] [Related]
13. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY. Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827 [Abstract] [Full Text] [Related]
14. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques. Gonçalves I, Gronholdt ML, Söderberg I, Ares MP, Nordestgaard BG, Bentzon JF, Fredrikson GN, Nilsson J. Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809 [Abstract] [Full Text] [Related]
15. Relationship between serum antioxidant vitamins A, E, and C and lipid profiles in priest subjects at the Priest Hospital. Viroonudomphol D, Mahaisiriyodom A, Mingkhawn R, Sadomthian P, Korchasri N, Jittngamkhum S, Sangcakul A. Southeast Asian J Trop Med Public Health; 2005 Jun; 36 Suppl 4():246-53. PubMed ID: 16438218 [Abstract] [Full Text] [Related]
16. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Al-Quobaili FA, Abou Asali IE. Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691 [Abstract] [Full Text] [Related]
17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M. J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [Abstract] [Full Text] [Related]
18. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Chang CY, Chen JY, Ke D, Hu ML. Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235 [Abstract] [Full Text] [Related]
19. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators. J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447 [Abstract] [Full Text] [Related]
20. Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study. Hoffman RM, Garewal HS. Prev Med; 1999 Aug 09; 29(2):112-8. PubMed ID: 10446037 [Abstract] [Full Text] [Related] Page: [Next] [New Search]